Sonia Menon1, Davy Vanden Broeck2, Rodolfo Rossi3, Emilomo Ogbe4, Stacy Harmon5, Hillary Mabeya6. 1. International Centre for Reproductive Health, Ghent University, Ghent, Belgium; CDC Foundation, Atlanta, Georgia. Electronic address: soniasimonemenon@gmail.com. 2. International Centre for Reproductive Health, Ghent University, Ghent, Belgium; Faculty of Medicine and Health Sciences, Laboratory of Cell Biology and Histology, University of Antwerp, Antwerp, Belgium. 3. AMBIOR (Applied Molecular Biology Research Group), University of Antwerp, Antwerp, Belgium. 4. International Centre for Reproductive Health, Ghent University, Ghent, Belgium. 5. CDC Foundation, Atlanta, Georgia. 6. Moi University and Gynocare Fistula Centre, Eldoret, Kenya.
Abstract
PURPOSE: Infection with and persistence of high-risk human papillomavirus (HR HPV) are the strongest risk factors for cervical cancer. Little is known about the prevalence and role of concurrent sexually transmitted infections (STIs) found in HPV-infected female sex workers (FSW) in Africa. This study purports to test our a priori hypotheses that STIs are associated with genotypes pertaining to the α-group species 9. The objectives were to determine the prevalence of bacterial vaginosis (BV), Trichomonas vaginalis, and Candida spp in FSW, the association between these STIs and the prevalence of any potential HR and HR HPV genotypes in FSWs. METHODS: A cross-sectional study design of 616 FSW from Western Kenya aged between 18 and 61 years during 2009-2015 using a peer recruitment sampling strategy. Inclusion criteria for the study entailed female sex and >18 years of age and having engaged in transactional sex in exchange for money, goods, services, or drugs in the last 3 months. Women were excluded if they were pregnant, <18 years of age, had a history of cervical dysplasia or cancer, had current abnormal bleeding, or had a hysterectomy. FINDINGS: Of the FSW, 33.3% had HIV and 57.7% harbored a potential HR and HR HPV genotype. The 2 most prevalent potential HR and HR genotypes were HPV 16 (16.10%) and HPV 59 (12.20%). BV was the most common infection (48.3%), followed by Trichomonas vaginalis (31.4%) and Candida spp (19.9%). A multivariate regression revealed significant associations with both α-group 9 and 6; BV and HPV 58 (adjusted odds ratio [aOR] = 2.3; 95% CI, 1.0-5.2; P = 0.05), Trichomonas vaginalis and HPV 31 and HPV 35 (aOR = 2.0; 95% CI, 1.0-3.8; P = 0.04 and aOR = 1.8; 95% CI, 1.0-3.3, P = 0.05 respectively); and between Candida spp and HPV 53 (aOR = 2.0; 95% CI, 1.1-4.0; P = 0.03) and 16 (aOR = 1.9; 95% CI, 1.1-3.3; P = 0.03). IMPLICATIONS: Snowball sampling may have inadvertently excluded FSW less likely to benefit from a social network. Significant associations between BV and HPV 58 and between Candida spp and HPV 16 and 53 suggest the need for sexually transmitted disease management within a cervical cancer prevention program. The probable synergistic effects of the vaginal microbiota should be elucidated, especially within this vulnerable population. Given the potential for FSW to transmit STIs, robust epidemiologic sampling methods are urgently required that account for the heterogeneity of the FSW population.
PURPOSE:Infection with and persistence of high-risk human papillomavirus (HR HPV) are the strongest risk factors for cervical cancer. Little is known about the prevalence and role of concurrent sexually transmitted infections (STIs) found in HPV-infected female sex workers (FSW) in Africa. This study purports to test our a priori hypotheses that STIs are associated with genotypes pertaining to the α-group species 9. The objectives were to determine the prevalence of bacterial vaginosis (BV), Trichomonas vaginalis, and Candida spp in FSW, the association between these STIs and the prevalence of any potential HR and HR HPV genotypes in FSWs. METHODS: A cross-sectional study design of 616 FSW from Western Kenya aged between 18 and 61 years during 2009-2015 using a peer recruitment sampling strategy. Inclusion criteria for the study entailed female sex and >18 years of age and having engaged in transactional sex in exchange for money, goods, services, or drugs in the last 3 months. Women were excluded if they were pregnant, <18 years of age, had a history of cervical dysplasia or cancer, had current abnormal bleeding, or had a hysterectomy. FINDINGS: Of the FSW, 33.3% had HIV and 57.7% harbored a potential HR and HR HPV genotype. The 2 most prevalent potential HR and HR genotypes were HPV 16 (16.10%) and HPV 59 (12.20%). BV was the most common infection (48.3%), followed by Trichomonas vaginalis (31.4%) and Candida spp (19.9%). A multivariate regression revealed significant associations with both α-group 9 and 6; BV and HPV 58 (adjusted odds ratio [aOR] = 2.3; 95% CI, 1.0-5.2; P = 0.05), Trichomonas vaginalis and HPV 31 and HPV 35 (aOR = 2.0; 95% CI, 1.0-3.8; P = 0.04 and aOR = 1.8; 95% CI, 1.0-3.3, P = 0.05 respectively); and between Candida spp and HPV 53 (aOR = 2.0; 95% CI, 1.1-4.0; P = 0.03) and 16 (aOR = 1.9; 95% CI, 1.1-3.3; P = 0.03). IMPLICATIONS: Snowball sampling may have inadvertently excluded FSW less likely to benefit from a social network. Significant associations between BV and HPV 58 and between Candida spp and HPV 16 and 53 suggest the need for sexually transmitted disease management within a cervical cancer prevention program. The probable synergistic effects of the vaginal microbiota should be elucidated, especially within this vulnerable population. Given the potential for FSW to transmit STIs, robust epidemiologic sampling methods are urgently required that account for the heterogeneity of the FSW population.
Authors: Brett A Tortelli; Warren G Lewis; Jenifer E Allsworth; Nadum Member-Meneh; Lynne R Foster; Hilary E Reno; Jeffrey F Peipert; Justin C Fay; Amanda L Lewis Journal: Am J Obstet Gynecol Date: 2019-10-22 Impact factor: 8.661
Authors: Ilka Kassandra Pereira Belfort; Ana Paula Almeida Cunha; Francisco Pedro Belfort Mendes; Leonardo Victor Galvão-Moreira; Renata Gaspar Lemos; Lucas Henrique de Lima Costa; Pablo Monteiro; Mariele Borges Ferreira; Gerusinete Rodrigues Bastos Dos Santos; Joyce Leal Costa; Alice de Sá Ferreira; Luiz Gustavo Oliveira Brito; Luciane Maria Oliveira Brito; Flávia Castello Branco Vidal; Sally Cristina Moutinho Monteiro Journal: BMC Womens Health Date: 2021-04-23 Impact factor: 2.809
Authors: Aaron Ermel; Yan Tong; Phillip Tonui; Omenge Orang'o; Kapten Muthoka; Nelson Wong; Titus Manai; Stephen Kiptoo; Patrick J Loehrer; Darron R Brown Journal: Int J STD AIDS Date: 2021-07-07 Impact factor: 1.359
Authors: Jonah Musa; Supriya D Mehta; Chad J Achenbach; Charlesnika T Evans; Neil Jordan; Francis A Magaji; Victor C Pam; Patrick H Daru; Olugbenga A Silas; Atiene S Sagay; Rose Anorlu; Yinan Zheng; Mamoudou Maiga; Isaac F Adewole; Robert L Murphy; Lifang Hou; Melissa A Simon Journal: Infect Agent Cancer Date: 2020-07-29 Impact factor: 2.965
Authors: Kristen Sweet; Claire Bosire; Busola Sanusi; Carly J Sherrod; Jessie Kwatampora; Wairimu Waweru; Nelly Mugo; Joshua Kimani; Jie Ting; Jennifer Clark; Dirk P Dittmer; Jennifer S Smith Journal: Int J STD AIDS Date: 2020-01-16 Impact factor: 1.359